Mast cells and eicosanoid mediators: A system of reciprocal paracrine and autocrine regulation

Immunological Reviews

Volumn 217, Issue 1, 2007, Pages 168-185

  Boyce, Joshua A ^a,b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Partners Asthma Center   (United States)

Author keywords

Arachidonic acid; Inflammation; Leukotrienes; Mast cells; Prostaglandins

Indexed keywords

ARACHIDONIC ACID; G PROTEIN COUPLED RECEPTOR; LEUKOTRIENE B4; LEUKOTRIENE C4; PEPTIDOLEUKOTRIENE; PROSTAGLANDIN D SYNTHASE; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; RAMATROBAN;

ADAPTIVE IMMUNITY; ALLERGIC ASTHMA; ANTIGEN PRESENTATION; AUTOCRINE EFFECT; BLOOD VESSEL PERMEABILITY; BRONCHOSPASM; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL HETEROGENEITY; CELL MATURATION; CELL MIGRATION; FIBROSIS; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; INFLAMMATORY CELL; INNATE IMMUNITY; LEUKOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; MAST CELL; MICROVASCULARIZATION; NEUTROPHIL; NONHUMAN; PARACRINE SIGNALING; PNEUMONIA; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE FIBER;

ANIMALS; AUTOCRINE COMMUNICATION; EICOSANOIDS; HUMANS; MAST CELLS; MICE; PARACRINE COMMUNICATION;

EID: 34248226331     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.2007.00512.x     Document Type: Review

References (183)

1. Echtenacher B, Mannel DN, Hultner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996 381 : 75 79.
2. Donaldson LE, Schmitt E, Huntley JF, Newlands GF, Grencis RK. A critical role for stem cell factor and c-kit in host protective immunity to an intestinal helminth. Int Immunol 1996 8 : 559 567.
3. MacGlashan DW Jr., et al. Generation of leukotrienes by purified lung mast cells. J Clin Invest 1982 70 : 747 751.
4. Peters SP, et al. Arachidonic acid metabolism in purified human lung mast cells. J Immunol 1984 132 : 1972 1979.
5. Murray JJ, et al. Release of prostaglandin D2 into human airways during acute antigen challenge. N Engl J Med 1986 315 : 800 804.
6. Clark JD, et al. A novel arachidonic acid-selective cytosolic PLA2 contains a Ca2+-dependent translocation domain with homology to PKC and GAP. Cell 1992 65 : 1043 1051.
7. Berenbaum F, Humbert L, Bereziat G, Thirion S. Concomitant recruitment of ERK1/2 and p38 MAPK signalling pathway is required for activation of cytoplasmic phospholipase A2 via ATP in articular chondrocytes. J Biol Chem 2003 278 : 13680 13687.
8. Cho SH, You HJ, Woo CH, Yoo YJ, Kim JH. Rac and protein kinase C-δ regulate ERKs and cytosolic phospholipase A2 in FcεRI signaling to cysteinyl leukotriene synthesis in mast cells. J Immunol 2004 173 : 624 631.
9. Fujishima H, et al. Cytosolic phospholipase A2 is essential for both the immediate and the delayed phases of eicosanoid generation in mouse bone marrow-derived mast cells. Proc Natl Acad Sci USA 1999 96 : 4803 4807.
10. Murakami M, Matsumoto R, Austen KF, Arm JP. Prostaglandin endoperoxide synthase-1 and -2 couple to different transmembrane stimuli to generate prostaglandin D2 in mouse bone marrow-derived mast cells. J Biol Chem 1994 269 : 22269 22275.
11. Urade Y, et al. Mast cells contain spleen-type prostaglandin D synthetase. J Biol Chem 1990 265 : 371 375.
12. Urade Y, Fujimoto N, Hayaishi O. Purification and characterization of rat brain prostaglandin D synthetase. J Biol Chem 1985 260 : 12410 12415.
13. Lu R, Kanai N, Bao Y, Schuster VL. Cloning, in vitro expression, and tissue distribution of a human prostaglandin transporter cDNA (hPGT). J Clin Invest 1996 98 : 1142 1149.
14. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, Lehmann JM. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor-γ and promotes adipocyte differentiation. Cell 1995 83 : 813 819.
15. Bochenek G, Nizankowska E, Gielicz A, Swierczynska M, Szczeklik A. Plasma 9α, 11β-PGF2, a PGD2 metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma. Thorax 2004 59 : 459 464.
16. Wenzel SE, Westcott JY, Smith HR, Larsen GL. Spectrum of prostanoid release after bronchoalveolar allergen challenge in atopic asthmatics and in control groups: an alteration in the ratio of bronchoconstrictive to bronchoprotective mediators. Am Rev Respir Dis 1989 139 : 450 457.
17. Hardy CC, Robinson C, Tattersfield AE, Holgate ST. The bronchoconstrictor effect of inhaled prostaglandin D2 in normal and asthmatic men. N Engl J Med 1984 311 : 209 213.
18. Fuller RW, Dixon CM, Dollery CT, Barnes PJ. Prostaglandin D2 potentiates airway responsiveness to histamine and methacholine. Am Rev Respir Dis 1986 133 : 252 254.
19. Soter NA, Lewis RA, Corey EJ, Austen KF. Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4, and LTB4) in human skin. J Invest Dermatol 1983 80 : 115 119.
20. Roberts LJ II., Turk JW, Oates JA. Shock syndrome associated with mastocytosis: pharmacologic reversal of the acute episode and therapeutic prevention of recurrent attacks. Adv Shock Res 1982 8 : 145 152.
21. Hirata M, Kakizuka A, Aizawa M, Ushikubi F, Narumiya S. Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene. Proc Natl Acad Sci USA 1994 91 : 11192 11196.
22. Boie Y, Sawyer N, Slipetz DM, Metters KM, Abramovitz M. Molecular cloning and characterization of the human prostanoid DP receptor. J Biol Chem 1995 270 : 18910 18916.
23. Hirai H, et al. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med 2001 193 : 255 261.
24. Sawyer N, et al. Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2. Br J Pharmacol 2002 137 : 1163 1172.
25. Yoshimura-Uchiyama C, et al. Differential modulation of human basophil functions through prostaglandin D receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2. Clin Exp Allergy 2004 34 : 1283 1290.
26. Gervais FG, et al. Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP. J Allergy Clin Immunol 2001 108 : 982 988.
27. Gosset P, et al. Prostaglandin D2 affects the maturation of human monocyte-derived dendritic cells: consequence on the polarization of naive Th cells. J Immunol 2003 170 : 4943 4952.
28. Xue L, et al. Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells. J Immunol 2005 175 : 6531 6536.
29. Johnston SL, Bardin PG, Harrison J, Ritter W, Joubert JR, Holgate ST. The effects of an oral thromboxane TP receptor antagonist BAY u 3405, on prostaglandin D2- and histamine-induced bronchoconstriction in asthma, and relationship to plasma drug concentration. Br J Clin Pharmacol 1992 34 : 2 8.
30. Kinsella BT, O'Mahony DJ, Fitzgerald GA. The human thromboxane A2 receptor alpha isoform (TPα) functionally couples to the G proteins Gq and G11 in vivo and is activated by the isoprostane 8-epi prostaglandin F2α. J Pharmacol Exp Ther 1997 281 : 957 964.
31. Bohm E, et al. 11-Dehydro-thromboxane B2, a stable thromboxane metabolite, is a full agonist of chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2) in human eosinophils and basophils. J Biol Chem 2004 279 : 7663 7670.
32. Sugimoto H, et al. An orally bioavailable small molecule antagonist of CRTH2, ramatroban (BAY u3405), inhibits prostaglandin D2-induced eosinophil migration in vitro. J Pharmacol Exp Ther 2003 305 : 347 352.
33. Martin TR, Gerard NP, Galli SJ, Drazen JM. Pulmonary responses to bronchoconstrictor agonists in the mouse. J Appl Physiol 1988 64 : 2318 2323.
34. Fujitani Y, Kanaoka Y, Aritake K, Uodome N, Okazaki-Hatake K, Urade Y. Pronounced eosinophilic lung inflammation and Th2 cytokine release in human lipocalin-type prostaglandin D synthase transgenic mice. J Immunol 2002 168 : 443 449.
35. Honda K, et al. Prostaglandin D2 reinforces Th2 type inflammatory responses of airways to low-dose antigen through bronchial expression of macrophage-derived chemokine. J Exp Med 2003 198 : 533 543.
36. Matsuoka T, et al. Prostaglandin D2 as a mediator of allergic asthma. Science 2000 287 : 2013 2017.
37. Spik I, et al. Activation of the prostaglandin D2 receptor DP2/CRTH2 increases allergic inflammation in mouse. J Immunol 2005 174 : 3703 3708.
38. Chevalier E, et al. Cutting edge: chemoattractant receptor-homologous molecule expressed on Th2 cells plays a restricting role on IL-5 production and eosinophil recruitment. J Immunol 2005 175 : 2056 2060.
39. Hammad H, de Heer HJ, Soullie T, Hoogsteden HC, Trottein F, Lambrecht BN. Prostaglandin D2 inhibits airway dendritic cell migration and function in steady state conditions by selective activation of the D prostanoid receptor 1. J Immunol 2003 171 : 3936 3940.
40. Mandal AK, et al. Uteroglobin represses allergen-induced inflammatory response by blocking PGD2 receptor-mediated functions. J Exp Med 2004 199 : 1317 1330.
41. Malavia R, Malavia R, Jakschik BA. Reversible translocation of 5-lipoxygenase in mast cells upon IgE/antigen stimulation. J Biol Chem 1993 268 : 4939 4944.
42. Dixon RA, et al. Requirement of a 5-lipoxygenase-activating protein for leukotriene biosynthesis. Nature 1990 343 : 282 284.
43. Evans JF, Dupuis P, Ford-Hutchinson AW. Purification and characterisation of leukotriene A4 hydrolase from rat neutrophils. Biochim Biophys Acta 1985 840 : 43 50.
44. Lam BK, Penrose JF, Freedman GJ, Austen KF. Expression cloning of a cDNA for human leukotriene C4 synthase, a novel integral membrane protein conjugating reduced glutathione to leukotriene A4. Proc Natl Acad Sci USA 1994 91 : 7663 7669.
45. Jakobsson PJ, Thoren S, Morgenstern R, Samuelsson B. Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Sci USA 1999 96 : 7220 7225.
46. Lam BK, Gagnon L, Austen KF, Soberman RJ. The mechanism of leukotriene B4 export from human polymorphonuclear leukocytes. J Biol Chem 1990 265 : 13438 13441.
47. Lam BK, Owen WF, Austen KF, Soberman RJ. The identification of a distinct export step following the biosynthesis of leukotriene C4 by human eosinophils. J Biol Chem 1989 264 : 12885 12891.
48. Leier I, Jedlitschky G, Buchholz U, Cole SPC, Deeley RG, Keppler D. The MRP1 gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J Biol Chem 1994 269 : 27807 27810.
49. Anderson ME, Allison RD, Meister A. Interconversion of leukotrienes catalyzed by purified γ-glutamyl transpeptidase: concomitant formation of leukotriene D4 and γ-glutamyl amino acids. Proc Natl Acad Sci USA 1982 79 : 1088 1091.
50. Carter BZ, Shi ZZ, Barrios R, Lieberman MW. Gamma glutamyl leukotrienase, a gamma glutamyl transpeptidase gene family member, is expressed primarily in the spleen. J Biol Chem 1998 273 : 28277 28285.
51. Shi ZZ, Han B, Habib GM, Matzuk MM, Lieberman MW. Disruption of gamma-glutamyl leukotrienase results in disruption of leukotriene D (4) synthesis in vivo and attenuation of the acute inflammatory response. Mol Cell Biol 2001 21 : 5389 5395.
52. Lee CW, Lewis RA, Corey EJ, Austen KF. Conversion of leukotriene D4 to leukotriene E4 by a dipeptidase released from the specific granules of human polymorphonuclear leukocytes. Immunology 1983 48 : 27 35.
53. Drazen JM, et al. Recovery of leukotriene E4 from the urine of patients with airway obstruction. Am Rev Respir Dis 1992 146 : 104 108.
54. Wenzel SE, Larsen GL, Johnston K, Voelkel NF, Westcott JY. Elevated levels of leukotriene C4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge. Am Rev Respir Dis 1990 142 : 112 119.
55. Dahlen SE, Hedqvist P, Hammarstrom S, Samuelsson B. Leukotrienes are potent constrictors of human bronchi. Nature 1980 288 : 484 486.
56. Hanna CJ, Bach MK, Pare PD, Schellenberg RR. Slow-reacting substances (leukotrienes) contract human airway and pulmonary vascular smooth muscle in vitro. Nature 1981 290 : 343 344.
57. Findlay SR, Lichtenstein LM, Siegel H, Triggle DJ. Mechanisms of contraction induced by partially purified slow reacting substance from human polymorphonuclear leukocytes and leukotriene D in guinea pig ileal smooth muscle. J Immunol 1981 126 : 1728 1730.
58. Davidson AB, et al. Bronchoconstrictor effects of leukotriene E4 in normal and asthmatic subjects. Am Rev Respir Dis 1987 135 : 333 337.
59. Laitinen LA, Laitinen A, Haahtela T, Vilkka V, Spur BW, Lee TH. Leukotriene E4 and granulocytic infiltration into asthmatic airways. Lancet 1993 341 : 989 990.
60. Austen KF, Corey EJ, Drazen JM, Leitch AG. The effect of indomethacin on the contractile response of the guinea-pig lung parenchymal strip to leukotrienes B4, C4, D4 and E4. Br J Pharmacol 1983 80 : 47 53.
61. Csoma Z, Kharitonov SA, Balint B, Bush A, Wilson NM, Barnes PJ. Increased leukotrienes in exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med 2002 166 : 1345 1349.
62. Vachier I, et al. Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound. J Allergy Clin Immunol 2005 115 : 55 60.
63. Sehmi R, Wardlaw AJ, Cromwell O, Kurihara K, Waltmann P, Kay AB. Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. Blood 1992 79 : 2952 2959.
64. Lynch KR, et al. Characterization of the human cysteinyl leukotriene cysLT1 receptor. Nature 1999 399 : 789 793.
65. Heise CE, et al. Characterization of the human cysteinyl leukotriene 2 receptor. J Biol Chem 2000 275 : 30531 30536.
66. Martin V, et al. Molecular cloning and functional characterization of murine cysteinyl-leukotriene 1 (CysLT1) receptor. Biochem Pharmacol 2001 62 : 1193 1200.
67. Hui Y, et al. The murine cysteinyl leukotriene 2 (CysLT2) receptor: cDNA and genomic cloning, alternative splicing, and in vitro characterization. J Biol Chem 2001 276 : 47489 47495.
68. Lee TH, Austen KF, Corey EJ, Drazen JM. Leukotriene E4-induced airway hyperresponsiveness of guinea pig tracheal smooth muscle to histamine and evidence for three separate sulfidopeptide leukotriene receptors. Proc Nat Acad Sci USA 1984 81 : 4922 4925.
69. Arm JP, et al. Asthmatic airways have a disproportionate hyperresponsiveness to LTE4, as compared with normal airways, but not to LTC4, LTD4, methacholine, and histamine. Am Rev Respir Dis 1990 142 : 1112 1118.
70. Figueroa DJ, et al. Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes. Am J Respir Crit Care Med 2001 163 : 226 233.
71. Figueroa DJ, Borish L, Baramki D, Philip G., Austin CP, Evans JF. Expression of cysteinyl leukotriene synthetic and signalling proteins in inflammatory cells in active seasonal allergic rhinitis. Clin Exp Allergy 2003 33 : 1380 1388.
72. Zhu J, et al. Localization and upregulation of cysteinyl leukotriene-1 receptor in asthmatic bronchial mucosa. Am J Respir Cell Mol Biol 2005 33 : 531 540.
73. Corrigan C, et al. Expression of the cysteinyl leukotriene receptors CysLT1 and CysLT2 in aspirin-sensitive and aspirin-tolerant chronic rhinosinusitis. J Allergy Clin Immunol 2005 115 : 316 322.
74. Sjostrom M, Johansson AS, Schroder O, Qiu H, Palmblad J, Haeggstrom JZ. Dominant expression of the CysLT2 receptor accounts for calcium signaling by cysteinyl leukotrienes in human umbilical vein endothelial cells. Arterioscler Thromb Vasc Biol 2003 23 : 37 41.
75. Yokomizo T, Izumi T, Chang K, Takuwa Y, Shimizu T. A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis. Nature 1997 387 : 620 624.
76. Yokomizo T, Kato K, Terawaki K, Izumi T, Shimizu T. A second leukotriene B4 receptor, BLT2. A new therapeutic target in inflammation and immunological disorders. J Exp Med 2000 192 : 421 432.
77. Iizuka Y, Yokomizo T, Terawaki K, Komine M, Tamaki K, Shimizu T. Characterization of a mouse second leukotriene B4 receptor, mBLT2: BLT2-dependent ERK activation and cell migration of primary mouse keratinocytes. J Biol Chem 2005 280 : 24816 24823.
78. Panettieri RA, Tan EM, Ciocca V, Luttmann MA, Leonard TB, Hay DW. Effects of LTD4 on human airway smooth muscle cell proliferation, matrix expression, and contraction in vitro: differential sensitivity to cysteinyl leukotriene receptor antagonists. Am J Respir Cell Mol Biol 1998 19 : 453 461.
79. Espinosa K, Bosse Y, Stankova J, Rola-Pleszczynski M. CysLT1 receptor upregulation by TGFβ and IL-13 is associated with bronchial smooth muscle cell proliferation in response to LTD4. J Allergy Clin Immunol 2003 111 : 1032 1040.
80. Paruchuri S, Broom O, Dib K, Sjolander A. The pro-inflammatory mediator leukotriene D4 induces phosphatidylinositol 3-kinase and Rac-dependent migration of intestinal epithelial cells. J Biol Chem 2005 280 : 13538 13544.
81. Paruchuri S, Sjolander A. Leukotriene D4 mediates survival and proliferation via separate but parallel pathways in the human intestinal epithelial cell line Int 407. J Biol Chem 2003 278 : 45577 45585.
82. Uzonyi B, et al. Cysteinyl leukotriene 2 receptor and protease-activated receptor 1 activate strongly correlated early genes in human endothelial cells. Proc Natl Acad Sci USA 2006 103 : 6326 6331.
83. Sakata K, Dahlen SE, Back M. The contractile action of leukotriene B4 in the guinea-pig lung involves a vascular component. Br J Pharmacol 2004 141 : 449 456.
84. Qiu H, et al. Differential induction of BLT receptor expression on human endothelial cells by lipopolysaccharide, cytokines, and leukotriene B4. Proc Natl Acad Sci USA 2006 103 : 6913 6918.
85. Qiu H, et al. Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability. Proc Natl Acad Sci USA 2006 103 : 8161 8166.
86. Heller EA, et al. Inhibition of atherogenesis in BLT1-deficient mice reveals a role for LTB4 and BLT1 in smooth muscle cell recruitment. Circulation 2005 112 : 578 586.
87. Jeziorska M, McCollum C, Woolley DE. Mast cell distribution, activation, and phenotype in atherosclerotic lesions of human carotid arteries. J Pathol 1997 182 : 115 122.
88. Bautz F, Denzlinger C, Kanz L, Mohle R. Chemotaxis and transendothelial migration of CD34+ hematopoietic progenitor cells induced by the inflammatory mediator leukotriene D4 are mediated by the 7-transmembrane receptor CysLT1. Blood 2001 97 : 3433 3440.
89. Mita H, Hasegawa M, Saito H, Akiyama K. Levels of cysteinyl leukotriene receptor mRNA in human peripheral leucocytes: significantly higher expression of cysteinyl leukotriene receptor 2 mRNA in eosinophils. Clin Exp Allergy 2001 31 : 1714 1723.
90. Bandeira-Melo C, Hall JC, Penrose JF, Weller PF. Cysteinyl leukotrienes induce IL-4 release from cord blood-derived human eosinophils. J Allergy Clin Immunol 2002 109 : 975 979.
91. Bandeira-Melo C, Woods LJ, Phoofolo M, Weller PF. Intracrine cysteinyl leukotriene receptor-mediated signaling of eosinophil vesicular transport-mediated interleukin-4 secretion. J Exp Med 2002 196 : 841 850.
92. Thivierge M, Doty M, Johnson J, Stankova J, Rola-Pleszczynski M. IL-5 up-regulates cysteinyl leukotriene 1 receptor expression in HL-60 cells differentiated into eosinophils. J Immunol 2000 165 : 5221 5226.
93. Thivierge M, Stankova J, Rola-Pleszczynski M. IL-13 and IL-4 up-regulate cysteinyl leukotriene 1 receptor expression in human monocytes and macrophages. J Immunol 2001 167 : 2855 2860.
94. Lamoureux J, Stankova J, Rola-Pleszczynski M. Leukotriene D4 enhances immunoglobulin production in CD40-activated human B lymphocytes. J Allergy Clin Immunol 2006 117 : 924 930.
95. Mellor EA, Austen KF, Boyce JA. Cysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cells. Proc Natl Acad Sci USA 2001 98 : 7964 7969.
96. Lin DA, Boyce JA. IL-4 regulates MEK expression required for lysophosphatidic acid-mediated chemokine generation by human mast cells. J Immunol 2005 175 : 5430 5438.
97. Mellor EA, Austen KF, Boyce JA. Cysteinyl leukotrienes and uridine diphosphate induce cytokine generation by human mast cells through an interleukin 4-regulated pathway that is inhibited by leukotriene receptor antagonists. J Exp Med 2002 195 : 583 592.
98. Burke JR, Davern LB, Gregor KR, Tramposch KM. Leukotriene B4 stimulates the release of arachidonate in human neutrophils via the action of cytosolic phospholipase A2. Biochim Biophys Acta 1997 1359 : 80 88.
99. Gaudreault E, Thompson C, Stankova J, Rola-Pleszczynski M. Involvement of BLT1 endocytosis and Yes kinase activation in leukotriene B4-induced neutrophil degranulation. J Immunol 2005 174 : 3617 3625.
100. Iikura M, et al. 5-Lipoxygenase products regulate basophil functions: 5-Oxo-ETE elicits migration and leukotriene B4 induces degranulation. J Allergy Clin Immunol 2005 116 : 578 585.
101. Goodarzi K, Goodarzi M, Tager AM, Luster AD, von Andrian UH. Leukotriene B4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues. Nat Immunol 2003 4 : 965 973.
102. Israel E, Cohn J, Dube L, Drazen JM. Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. JAMA 1996 275 : 931 936.
103. Altman LC, et al. A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group. J Allergy Clin Immunol 1998 102 : 50 56.
104. Yoshida S, et al. Effect of pranlukast on bronchial inflammation in patients with asthma. Clin Exp Allergy 2000 30 : 1008 1014.
105. Hamilton A, Faiferman I, Stober P, Watson RM, O'Byrne PM. Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects. J Allergy Clin Immunol 1998 102 : 177 183.
106. Melo RE, et al. Exercise-induced bronchoconstriction in children: montelukast attenuates the immediate-phase and late-phase responses. J Allergy Clin Immunol 2003 111 : 301 307.
107. Richter K, Jorres RA, Magnussen H. Efficacy and duration of action of the antileukotriene zafirlukast on cold air-induced bronchoconstriction. Eur Respir J 2000 15 : 693 699.
108. Rorke S, Jennison S, Jeffs JA, Sampson AP, Arshad H, Holgate ST. Role of cysteinyl leukotrienes in adenosine 5′-monophosphate induced bronchoconstriction in asthma. Thorax 2002 57 : 323 327.
109. Camargo CA Jr., Smithline HA, Malice MP, Green SZA, Reiss TF. A randomized controlled trial of intravenous montelukast in acute asthma. Am J Respir Crit Care Med 2003 167 : 528 533.
110. Richter M, Sirois P. Effects of eicosanoids, neuromediators and bioactive peptides on murine airways. Eur J Pharmacol 2000 389 : 225 234.
111. Kanaoka Y, Maekawa A, Penrose JF, Austen KF, Lam BK. Attenuated zymosan-induced peritoneal vascular permeability and IgE-dependent passive cutaneous anaphylaxis in mice lacking leukotriene C4 synthase. J Biol Chem 2001 276 : 22608 22613.
112. Maekawa A, Austen KF, Kanaoka Y. Targeted gene disruption reveals the role of cysteinyl leukotriene 1 receptor in the enhanced vascular permeability of mice undergoing acute inflammatory responses. J Biol Chem 2002 277 : 20820 20824.
113. Beller TC, Maekawa A, Friend DS, Austen KF, Kanaoka Y. Targeted gene disruption reveals the role of the cysteinyl leukotriene 2 receptor in increased vascular permeability and in bleomycin-induced pulmonary fibrosis in mice. J Biol Chem 2004 279 : 46129 46134.
114. Heinsbroek SE, et al. Expression of functionally different dectin-1 isoforms by murine macrophages. J Immunol 2006 176 : 5513 5518.
115. Olynych TJ, Jakeman DL, Marshall JS. Fungal zymosan induces leukotriene production by human mast cells through a dectin-1-dependent mechanism. J Allergy Clin Immunol 2006 118 : 837 843.
116. Byrum RS, Goulet JL, Snouwaert JN, Griffiths RJ, Koller BH. Determination of the contribution of cysteinyl leukotrienes and leukotriene B4 in acute inflammatory responses using 5-lipoxygenase- and leukotriene A4 hydrolase-deficient mice. J Immunol 1999 163 : 6810 6819.
117. Malaviya R, Abraham SN. Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis. J Leukoc Biol 2000 67 : 841 846.
118. Benjamim CF, Canetti C, Cunha FQ, Kunkel SL, Peters-Golden M. Opposing and hierarchical roles of leukotrienes in local innate immune versus vascular responses in a model of sepsis. J Immunol 2005 174 : 1616 1620.
119. Bailie MB, Standiford TJ, Laichalk LL, Coffey MJ, Strieter R, Peters-Golden M. Leukotriene-deficient mice manifest enhanced lethality from Klebsiella pneumonia in association with decreased alveolar macrophage phagocytic and bactericidal activities. J Immunol 1996 157 : 5221 5224.
120. Irvin CG, Tu YP, Sheller JP, Funk CD. 5-Lipoxygenase products are necessary for ovalbumin-induced airway responsiveness in mice. Am J Physiol 1997 272 : L1053 L1058.
121. Henderson W, et al. The importance of leukotrienes in airway inflammation in a mouse model of asthma. J Exp Med 1997 184 : 1483 1494.
122. Uozumi N, et al. Role of cytosolic phospholipase A2 in allergic response and parturition. Nature 1997 390 : 618 622.
123. Kim DC, et al. Cysteinyl leukotrienes regulate Th2 cell-dependent pulmonary inflammation. J Immunol 2006 176 : 4440 4448.
124. Henderson WR, et al. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am J Respir Crit Care Med 2002 165 : 108 116.
125. Henderson WR Jr., Chiang GK, Tien YT, Chi EY. Reversal of allergen-induced airway remodeling by CysLT1 receptor blockade. Am J Respir Crit Care Med 2006 173 : 718 728.
126. Miyahara N, et al. Effector CD8+ T cells mediate inflammation and airway hyper-responsiveness. Nat Med 2004 10 : 865 869.
127. Tager AM, et al. Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment. Nat Immunol 2003 4 : 982 990.
128. Terawaki K, et al. Absence of leukotriene B4 receptor 1 confers resistance to airway hyperresponsiveness and Th2-type immune responses. J Immunol 2005 175 : 4217 4225.
129. Miyahara N, et al. Requirement for leukotriene B4 receptor 1 in allergen-induced airway hyperresponsiveness. Am J Respir Crit Care Med 2005 172 : 161 167.
130. Miyahara N, et al. Leukotriene B4 receptor-1 is essential for allergen-mediated recruitment of CD8+ T cells and airway hyperresponsiveness. J Immunol 2005 174 : 4979 4984.
131. Taube C, et al. The leukotriene B4 receptor (BLT1) is required for effector CD8+ T cell-mediated, mast cell-dependent airway hyperresponsiveness. J Immunol 2006 176 : 3157 3164.
132. Robbiani DF, Finch RA, Jager D, Muller WA, Sartorelli AC, Randolph GJ. The leukotriene C4 transporter MRP1 regulates CCL19 (MIP-3β, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell 2000 103 : 757 768.
133. Machida I, et al. Cysteinyl leukotrienes regulate dendritic cell functions in a murine model of asthma. J Immunol 2004 172 : 1833 1838.
134. Finkelman FD, et al. Cytokine regulation of host defense against parasitic gastrointestinal nematodes. Annu Rev Immunol 1997 15 : 505 533.
135. Ruitenberg EJ, Elgersma A. Absence of intestinal mast cell response in congenitally athymic mice during Trichinella spiralis infection. Nature 1976 264 : 258 260.
136. Lantz CS, et al. Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature 1998 392 : 90 93.
137. Madden KB, Urban JF Jr., Ziltener HJ, Schrader JW, Finkelman FD, Katona IM. Antibodies to IL-3 and IL-4 suppress helminth-induced intestinal mastocytosis. J Immunol 1991 147 : 1387 1391.
138. Irani AM, Craig S, DeBlois G, Elson CO, Schechter NM, Schwartz LB. Deficiency of the tryptase-positive, chymase-negative mast cell type in gastrointestinal mucosa of patients with defective T lymphocyte function. J Immunol 1987 138 : 4381 4386.
139. Laitinen LA, Laitinen A, Haahtela T. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis 1993 147 : 697 704.
140. Anderson DF, et al. Seasonal allergic conjunctivitis is accompanied by increased mast cell numbers in the absence of leukocyte infiltration. Clin Exp Allergy 1997 27 : 1060 1066.
141. Amin K, et al. Inflammatory cell and epithelial characteristics of perennial allergic and nonallergic rhinitis with a symptom history of 1 to 3 years' duration. J Allergy Clin Immunol 2001 107 : 249 257.
142. Straumann A, Bauer M, Fischer B, Blaser K, Simon HU. Idiopathic eosinophilic esophagitis is associated with a Th2-type allergic inflammatory response. J Allergy Clin Immunol 2002 108 : 954 961.
143. Rennick D, Hunte B, Holland G, Thompson-Snipes L. Cofactors are essential for stem cell factor-dependent growth and maturation of mast cell progenitors: comparative effects of interleukin-3 (IL-3), IL-4, IL-10, and fibroblasts. Blood 1995 85 : 57 65.
144. Temann UA, Geba GP, Rankin JA, Flavell RA. Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness. J Exp Med 1998 188 : 1307 1320.
145. Ochi H, et al. T helper type-2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro. J Exp Med 1999 190 : 267 280.
146. Yanagida M, et al. Effects of T-helper 2-type cytokines, interleukin-3 (IL-3), IL-4, IL-5, and IL-6 on the survival of cultured human mast cells. Blood 1995 86 : 3705 3714.
147. Matsuzawa S, Sakashita K, Kinoshita T, Ito S, Yamashita T, Koike K. IL-9 enhances the growth of human mast cell progenitors under stimulation with stem cell factor. J Immunol 2003 170 : 3461 3467.
148. Bischoff SC, Sellge G, Lorentz A, Sebald W, Raab R, Manns MP. IL-4 enhances proliferation and mediator release in mature human mast cells. Proc Natl Acad Sci USA 1999 96 : 8080 8085.
149. Heavey DJ, Ernst PB, Stevens RL, Befus AD, Bienenstock J, Austen KF. Generation of leukotriene C4, leukotriene B4, and prostaglandin D2 by immunologically activated rat intestinal mucosa mast cells. J Immunol 1988 140 : 1953 1957.
150. Lawrence ID, Warner JA, Cohan VL, Hubbard WC, Kagey-Sobotka A, Lichtenstein LM. Purification and characterization of human skin mast cells. Evidence for human mast cell heterogeneity. J Immunol 1987 139 : 3062 3069.
151. Fox CC, Duorak AM, Peters SP, Kogey-Sobotka A, Lichtenstein LM. Isolation and characterization of human intestinal mucosal mast cells. J Immunol 1985 135 : 483 491.
152. Massey WA, et al. Human uterine mast cells. Isolation, purification, characterization, ultrastructure, and pharmacology. J Immunol 1991 147 : 1621 1627.
153. Murakami M, Matsumoto R, Urade Y, Austen KF., Arm JP. c-kit ligand mediates increased expression of cytosolic phospholipase A2, prostaglandin endoperoxide synthase-1, and hematopoietic prostaglandin D2 synthase and increased IgE-dependent prostaglandin D2 generation in immature mouse mast cells. J Biol Chem 1995 270 : 3239 3246.
154. Li L, Yang Y, Stevens RL. RasGRP4 regulates the expression of prostaglandin D2 in human and rat mast cell lines. J Biol Chem 2003 278 : 4725 4729.
155. Morii E, Oboki K. MITF is necessary for generation of prostaglandin D2 in mouse mast cells. J Biol Chem 2004 279 : 48923 48929.
156. Kitamura Y, Go S, Hatanaka K. Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. Blood 1978 52 : 447 452.
157. Murakami M, Austen KF, Bingham CO III., Friend DS, Penrose JF, Arm JP. Interleukin-3 regulates development of the 5-lipoxygenase/leukotriene C4 synthase pathway in mouse mast cells. J Biol Chem 1995 270 : 22653 22656.
158. Hsieh FH, Lam BK, Penrose JF, Austen KF, Boyce JA. T helper cell type 2 cytokines coordinately regulate IgE-dependent cysteinyl leukotriene production by human cord blood-derived mast cells: profound induction of leukotriene C4 synthase expression by interleukin 4. J Exp Med 2001 193 : 123 133.
159. Mellor EA, et al. Expression of the CysLT2 receptor by human mast cells; demonstration of function separate from that of CysLT1 receptor. Proc Natl Acad Sci USA 2003 100 : 11589 11593.
160. Jiang Y, Kanaoka Y, Feng CL, Nocka K, Rao S, Boyce JA. Cutting edge: interleukin 4-dependent mast cell proliferation requires autcrine/intracrine cysteinyl leukotriene-dependent signaling. J Immunol 2006 177 : 2755 2759.
161. Weller CL, et al. Leukotriene B4, an activation product of mast cells, is a chemoattractant for their progenitors. J Exp Med 2005 201 : 1961 1971.
162. Medoff BD, Tager AM, Jackobek R, Means TK, Wang L, Luster AD. Antibody-antigen interaction in the airway drives early granulocyte recruitment through BLT1. Am J Physiol Lung Cell Mol Physiol 2006 290 : 170 178.
163. Tanioka T, Nakatani Y, Semmyo N, Murakami M, Kudo I. Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. J Biol Chem 2000 275 : 32775 32782.
164. Murakami M, et al. Cellular prostaglanidin E2 production by membrane-bound prostaglandin E2 synthase-2 via both cyclooxygenases-1 and -2. J Biol Chem 2003 278 : 37937 37947.
165. Claveau D, et al. Microsomal prostaglandin e synthase-1 is a major terminal synthase that is selectively up-regulated during cyclooxygenase-2- dependent prostaglandin E2 production in the rat adjuvant-induced arthritis model. J Immunol 2002 170 : 4738 4744.
166. Kobayashi T, Narumiya S. Function of prostanoid receptors: studies on knockout mice. Prostaglandins Other Lipid Mediat 2002 68-69 : 557 573.
167. Gauvreau G, Watson R, O'Byrne P. Protective effects of inhaled PGE2 on allergen-induced airway responses and airway inflammation. Am J Respir Crit Care Med 1999 159 : 31 36.
168. Hartert T, Dworski R, Mellen B, Oates J, Murray J, Sheller J. Prostaglandin E2 decreases allergen-stimulated release of prostaglandin D2 in airways of subjects with asthma. Am J Respir Crit Care Med 2000 162 : 637 640.
169. Sestini P, et al. Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma. Am J Respir Crit Care Med 1996 153 : 572 575.
170. Szczeklik A, Mastalerz L, Nizankowska E, Cmiel A. Protective and bronchodilator effects of prostaglandin E and salbutamol in aspirin-induced asthma. Am J Respir Crit Care Med 1996 153 : 567 571.
171. Bonazzi A, et al. Effect of endogenous and exogenous prostaglandin E2 on interleukin-1 beta-induced cyclooxygenase-2 expression in human airway smooth-muscle cells. Am J Respir Crit Care Med 2000 162 : 2272 2277.
172. Kowalski ML, et al. Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients. Am J Respir Crit Care Med 2000 161 : 391 398.
173. Faour WH, et al. Prostaglandin E2 regulates the level and stability of cyclooxygenase-2 mRNA through activation of p38 mitogen-activated protein kinase in interleukin1β-treated human fibroblasts. J Biol Chem 2001 276 : 31720 31731.
174. Trudeau J, Hu H, Chibana K, Chu HW, Westcott JY, Wenzel SE. Selective downregulation of prostaglandin E2-related pathways by the TH2 cytokine IL-13. J Allergy Clin Immunol 2006 117 : 1446 1454.
175. Kaliner M, Austen K. Cyclic AMP, ATP, and reversed anaphylactic histamine release from rat mast cells. J Immunol 1974 112 : 664 674.
176. Peachell P, MacGlashan D Jr., Lichtenstein L, Schleimer R. Regulation of human basophil and lung mast cell function by cyclic adenosine monophosphate. J Immunol 1988 140 : 571 579.
177. Nguyen M, et al. Receptors and signaling mechanisms required for prostaglandin E2-mediated regulation of mast cell degranulation and IL-6 production. J Immunol 2002 169 : 4586 4593.
178. Abdel-Majid R, Marshall J. Prostaglandin E2 induces degranulation- independent production of vascular endothelial growth factor by human mast cells. J Immunol 2004 172 : 1227 1236.
179. Goulet J, et al. E-prostanoid-3 receptors mediate the proinflammatory actions of prostaglandin E2 in acute cutaneous inflammation. J Immunol 2004 173 : 1321 1326.
180. Feng C, Beller EM, Bagga S, Boyce JA. Human mast cells express multiple EP receptors for prostaglandin E2 that differentially modulate activation responses. Blood 2006 107 : 3243 3250.
181. Bodor J, Habener J. Role of transcriptional repressor ICER in cyclic AMP-mediated attenuation of cytokine gene expression in human thymocytes. J Biol Chem 1998 273 : 9544 9551.
182. Luo M, Jones SM, Flamand N, Aronoff DM, Peters-Golden M, Brock TG. Phosphorylation by protein kinase a inhibits nuclear import of 5-lipoxygenase. J Biol Chem 2005 280 : 40609 40616.
183. Meng Q, Scadding G, Parikh A, Corrigan CJ, Lee TH. Aspirin-sensitive rhinosinusitis is associated with reduced E-prostanoid 2 receptor expression on nasal mucosal inflammatory cells. J Allergy Clin Immunol 2006 117 : 312 318.